| Date | Analyst | Company | Last | Target | Call | Valuation |
| 11/29/17 | UOB Kay Hian | Tuan Sing | 0.415 | 0.71 | Buy | Sum of parts |
| 01/15/18 | UOB Kay Hian | Tuan Sing | 0.49 | 0.71 | Buy | |
| 01/29/18 | UOB Kay Hian | Tuan Sing | 0.48 | 0.71 | Buy | Sum of parts |
Subscribe to:
Post Comments (Atom)
New Launch - One Sophia For Sale!
Please click the advertisement for more information.
Special offer for CT Foodnex! Grab it before it ends!
Click for more details.
Featured Post
NATO and the US are the axis of calumnies!
NATO tried to shift and pin its reprehensive act on China when the fundamental cause of the war was orchestrated by the US. We had stated pr...
Popular Posts
-
Date Analyst Company Last Target Call Valuation 06/19/23 OCBC Keppel Infrastructure 0.49 0.605 Buy 07/27/23 DBS Vickers Keppel Infrastructur...
-
Date Analyst Company Last Target Call Valuation 11/20/23 phillip Vertex Tech 4.95 0 Fully Redeemed
-
Date Analyst Company Last Target Call Valuation 05/04/23 UOB Kay Hian Emperador 0.5 0.57 Hold PER31.5x FY23 08/25/23 UOB Kay Hian Emperador ...
-
Date Analyst Company Last Target Call Valuation 04/12/24 Lim & Tan Broadway Industrial 0.127 0 Accumulate
-
Date Analyst Company Last Target Call Valuation 05/31/23 Amfrasers Fortress Minerals 0.34 0.46 outperform DCF & EV/Resource3.6x 07/20/23...
-
Date Analyst Company Last Target Call Valuation 05/15/23 Lim & Tan Fu Yu 0.21 0 Sell
-
Date Analyst Company Last Target Call Valuation 09/25/23 Amfrasers Banyan Tree 0.4 0.415 Buy 04/04/24 Amfrasers Banyan Tree 0.385 0.41 Buy
-
Date Analyst Company Last Target Call Valuation 04/12/24 Lim & Tan Broadway Industrial 0.127 0 Accumulate
-
The US is trying to phase out cryptos such as bitcoin gradually by using its new carbon emission policies and crypto mining tax. The US has ... -
The 10year-3month treasury curve inversion has been an accurate US recession indicator insofar. A recession usually followed after a yield ...
Received Top 75 Singapore Investment Blogs Award in July 2017
Top 50 Singapore Investment Blogs
No comments:
Post a Comment